Cargando…
The developmental journey of therapies targeting purine receptors: from basic science to clinical trials
Since the discovery of ATP as an extracellular signalling molecule in 1972, purinergic signalling, mediated by extracellular purines and pyrimidines has been identified in virtually all mammalian tissues and is implicated in regulating fundamental cellular processes. In recent years, there has been...
Autores principales: | Han, Seunga, Suzuki-Kerr, Haruna, Vlajkovic, Srdjan M., Thorne, Peter R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832190/ https://www.ncbi.nlm.nih.gov/pubmed/36173587 http://dx.doi.org/10.1007/s11302-022-09896-w |
Ejemplares similares
-
Second meeting of the Australian and New Zealand Purine Club
por: Gubert, Carolina, et al.
Publicado: (2022) -
Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
por: Vlajkovic, Srdjan M., et al.
Publicado: (2021) -
Purinergic Signalling in the Cochlea
por: Vlajkovic, Srdjan M., et al.
Publicado: (2022) -
Inhibition of the Adenosine A(2A) Receptor Mitigates Excitotoxic Injury in Organotypic Tissue Cultures of the Rat Cochlea
por: Han, Belinda RX, et al.
Publicado: (2019) -
Purinergic Signaling and Aminoglycoside Ototoxicity: The Opposing Roles of P1 (Adenosine) and P2 (ATP) Receptors on Cochlear Hair Cell Survival
por: Lin, Shelly C. Y., et al.
Publicado: (2019)